1. Home
  2. WVE vs CAKE Comparison

WVE vs CAKE Comparison

Compare WVE & CAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • CAKE
  • Stock Information
  • Founded
  • WVE 2012
  • CAKE 1972
  • Country
  • WVE Singapore
  • CAKE United States
  • Employees
  • WVE N/A
  • CAKE N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • CAKE Restaurants
  • Sector
  • WVE Health Care
  • CAKE Consumer Discretionary
  • Exchange
  • WVE Nasdaq
  • CAKE Nasdaq
  • Market Cap
  • WVE 2.1B
  • CAKE 2.5B
  • IPO Year
  • WVE 2015
  • CAKE 1992
  • Fundamental
  • Price
  • WVE $10.99
  • CAKE $48.76
  • Analyst Decision
  • WVE Strong Buy
  • CAKE Hold
  • Analyst Count
  • WVE 10
  • CAKE 16
  • Target Price
  • WVE $21.60
  • CAKE $47.67
  • AVG Volume (30 Days)
  • WVE 1.0M
  • CAKE 1.2M
  • Earning Date
  • WVE 03-05-2025
  • CAKE 02-19-2025
  • Dividend Yield
  • WVE N/A
  • CAKE 2.21%
  • EPS Growth
  • WVE N/A
  • CAKE 52.49
  • EPS
  • WVE N/A
  • CAKE 2.64
  • Revenue
  • WVE $53,610,000.00
  • CAKE $3,537,745,000.00
  • Revenue This Year
  • WVE N/A
  • CAKE $5.95
  • Revenue Next Year
  • WVE $48.58
  • CAKE $5.32
  • P/E Ratio
  • WVE N/A
  • CAKE $18.48
  • Revenue Growth
  • WVE N/A
  • CAKE 2.39
  • 52 Week Low
  • WVE $3.50
  • CAKE $32.30
  • 52 Week High
  • WVE $16.74
  • CAKE $52.10
  • Technical
  • Relative Strength Index (RSI)
  • WVE 34.06
  • CAKE 49.99
  • Support Level
  • WVE $10.57
  • CAKE $47.88
  • Resistance Level
  • WVE $12.03
  • CAKE $51.00
  • Average True Range (ATR)
  • WVE 0.69
  • CAKE 1.40
  • MACD
  • WVE -0.17
  • CAKE -0.11
  • Stochastic Oscillator
  • WVE 12.54
  • CAKE 38.63

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About CAKE Cheesecake Factory Incorporated (The)

Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.

Share on Social Networks: